NYSE:ELV
Elevance Health Inc
Position levels
Currenttoday
USD 375.84
Buy <=wait / entry
USD 343.33
Trim >=take some off
USD 410.00
Thesis breakA guided medical loss ratio breach combined with a downward revision to full-yea...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 26% | 100 / 100 | 26.0 |
| Base case | 49% | 62 / 100 | 30.4 |
| Bear case | 25% | 10 / 100 | 2.5 |
| Weighted conviction | 59 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Q2 2026 EPS beat of $7.45 vs $6.20 estimate (+20.16%)
- Full-year 2026 adjusted diluted EPS guidance raised to at least $27.00
- Operating revenue of $49.8 billion, up 0.8% YoY driven by premium yields and CarelonRx growth